Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Catecholaminergic polymorphic ventricular tachycardia}} | {{Catecholaminergic polymorphic ventricular tachycardia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MRV}} | ||
== Overview == | == Overview == | ||
[[Exercise stress testing]] helps in establishing the diagnosis and [[genetic testing]] helps in confirming the diagnosis of catecholaminergic polymorphic ventricular tachycardia. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
*Catecholaminergic polymorphic ventricular tachycardia is a diagnosis based on reproducing ventricular arrhythmias during exercise stress testing, syncope occurring during physical activity and acute emotion, and a history of exercise or emotion-related palpitations and dizziness with an absence of structural cardiac abnormalities. | *Catecholaminergic polymorphic ventricular tachycardia is a diagnosis based on reproducing [[ventricular arrhythmias]] during exercise stress testing, [[syncope]] occurring during physical activity and acute emotion, and a history of exercise or emotion-related [[palpitations]] and [[dizziness]] with an absence of structural [[cardiac]] abnormalities. | ||
=== Study of choice === | === Study of choice === | ||
*[[Exercise stress testing]] is the gold standard test for the diagnosis of catecholaminergic polymorphic ventricular tachycardia.<ref name="ImbertiUnderwood2016">{{cite journal|last1=Imberti|first1=Jacopo F.|last2=Underwood|first2=Katherine|last3=Mazzanti|first3=Andrea|last4=Priori|first4=Silvia G.|title=Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Heart, Lung and Circulation|volume=25|issue=8|year=2016|pages=777–783|issn=14439506|doi=10.1016/j.hlc.2016.01.012}}</ref> | *[[Exercise stress testing]] is the gold standard test for the diagnosis of catecholaminergic polymorphic ventricular tachycardia.<ref name="ImbertiUnderwood2016">{{cite journal|last1=Imberti|first1=Jacopo F.|last2=Underwood|first2=Katherine|last3=Mazzanti|first3=Andrea|last4=Priori|first4=Silvia G.|title=Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Heart, Lung and Circulation|volume=25|issue=8|year=2016|pages=777–783|issn=14439506|doi=10.1016/j.hlc.2016.01.012}}</ref> | ||
*[[Genetic testing]] helps in confirming the diagnosis of catecholaminergic polymorphic ventricular tachycardia.<ref name="AckermanPriori2011">{{cite journal|last1=Ackerman|first1=M. J.|last2=Priori|first2=S. G.|last3=Willems|first3=S.|last4=Berul|first4=C.|last5=Brugada|first5=R.|last6=Calkins|first6=H.|last7=Camm|first7=A. J.|last8=Ellinor|first8=P. T.|last9=Gollob|first9=M.|last10=Hamilton|first10=R.|last11=Hershberger|first11=R. E.|last12=Judge|first12=D. P.|last13=Le Marec|first13=H.|last14=McKenna|first14=W. J.|last15=Schulze-Bahr|first15=E.|last16=Semsarian|first16=C.|last17=Towbin|first17=J. A.|last18=Watkins|first18=H.|last19=Wilde|first19=A.|last20=Wolpert|first20=C.|last21=Zipes|first21=D. P.|title=HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)|journal=Europace|volume=13|issue=8|year=2011|pages=1077–1109|issn=1099-5129|doi=10.1093/europace/eur245}}</ref><ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1289/# |title=Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | *[[Genetic testing]] helps in confirming the diagnosis of catecholaminergic polymorphic ventricular tachycardia.<ref name="AckermanPriori2011">{{cite journal|last1=Ackerman|first1=M. J.|last2=Priori|first2=S. G.|last3=Willems|first3=S.|last4=Berul|first4=C.|last5=Brugada|first5=R.|last6=Calkins|first6=H.|last7=Camm|first7=A. J.|last8=Ellinor|first8=P. T.|last9=Gollob|first9=M.|last10=Hamilton|first10=R.|last11=Hershberger|first11=R. E.|last12=Judge|first12=D. P.|last13=Le Marec|first13=H.|last14=McKenna|first14=W. J.|last15=Schulze-Bahr|first15=E.|last16=Semsarian|first16=C.|last17=Towbin|first17=J. A.|last18=Watkins|first18=H.|last19=Wilde|first19=A.|last20=Wolpert|first20=C.|last21=Zipes|first21=D. P.|title=HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)|journal=Europace|volume=13|issue=8|year=2011|pages=1077–1109|issn=1099-5129|doi=10.1093/europace/eur245}}</ref><ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1289/# |title=Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | ||
=== Diagnostic Criteria === | === Diagnostic Criteria === | ||
Latest revision as of 15:31, 23 July 2020
|
Catecholaminergic polymorphic ventricular tachycardia Microchapters |
|
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice |
|
FDA on Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice |
|
CDC on Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice |
|
Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice in the news |
|
Blogs on Catecholaminergic polymorphic ventricular tachycardia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Exercise stress testing helps in establishing the diagnosis and genetic testing helps in confirming the diagnosis of catecholaminergic polymorphic ventricular tachycardia.
Diagnostic Study of Choice
- Catecholaminergic polymorphic ventricular tachycardia is a diagnosis based on reproducing ventricular arrhythmias during exercise stress testing, syncope occurring during physical activity and acute emotion, and a history of exercise or emotion-related palpitations and dizziness with an absence of structural cardiac abnormalities.
Study of choice
- Exercise stress testing is the gold standard test for the diagnosis of catecholaminergic polymorphic ventricular tachycardia.[1]
- Genetic testing helps in confirming the diagnosis of catecholaminergic polymorphic ventricular tachycardia.[2][3]
Diagnostic Criteria
The diagnosis of CPVT is made when at least one of the following four diagnostic criteria are met:[4][5]
- CPVT is diagnosed in the presence of a structurally normal heart, normal ECG, and unexplained exercise or catecholamine-induced bidirectional VT, polymorphic ventricular premature beats or VT in individuals <40 years of age.
- CPVT is diagnosed in patients (index case or family member) who have a pathogenic mutation.
- CPVT is diagnosed in family members of a CPVT index case with a normal heart who manifest exercise-induced premature ventricular contractions or bidirectional/ polymorphic VT.
- CPVT can be diagnosed in the presence of a structurally normal heart and coronary arteries, normal ECG, and unexplained exercise or catecholamine-induced bidirectional VT, polymorphic ventricular premature beats or VT in individuals >40 years of age.
References
- ↑ Imberti, Jacopo F.; Underwood, Katherine; Mazzanti, Andrea; Priori, Silvia G. (2016). "Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia". Heart, Lung and Circulation. 25 (8): 777–783. doi:10.1016/j.hlc.2016.01.012. ISSN 1443-9506.
- ↑ Ackerman, M. J.; Priori, S. G.; Willems, S.; Berul, C.; Brugada, R.; Calkins, H.; Camm, A. J.; Ellinor, P. T.; Gollob, M.; Hamilton, R.; Hershberger, R. E.; Judge, D. P.; Le Marec, H.; McKenna, W. J.; Schulze-Bahr, E.; Semsarian, C.; Towbin, J. A.; Watkins, H.; Wilde, A.; Wolpert, C.; Zipes, D. P. (2011). "HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)". Europace. 13 (8): 1077–1109. doi:10.1093/europace/eur245. ISSN 1099-5129.
- ↑ "Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf".
- ↑ Priori, Silvia G.; Wilde, Arthur A.; Horie, Minoru; Cho, Yongkeun; Behr, Elijah R.; Berul, Charles; Blom, Nico; Brugada, Josep; Chiang, Chern-En; Huikuri, Heikki; Kannankeril, Prince; Krahn, Andrew; Leenhardt, Antoine; Moss, Arthur; Schwartz, Peter J.; Shimizu, Wataru; Tomaselli, Gordon; Tracy, Cynthia; Ackerman, Michael; Belhassen, Bernard; Estes, N. A. Mark; Fatkin, Diane; Kalman, Jonathan; Kaufman, Elizabeth; Kirchhof, Paulus; Schulze-Bahr, Eric; Wolpert, Christian; Vohra, Jitendra; Refaat, Marwan; Etheridge, Susan P.; Campbell, Robert M.; Martin, Edward T.; Quek, Swee Chye (2013). "Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes". EP Europace. 15 (10): 1389–1406. doi:10.1093/europace/eut272. ISSN 1532-2092.
- ↑ Priori, Silvia G.; Blomström-Lundqvist, Carina; Mazzanti, Andrea; Blom, Nico; Borggrefe, Martin; Camm, John; Elliott, Perry Mark; Fitzsimons, Donna; Hatala, Robert; Hindricks, Gerhard; Kirchhof, Paulus; Kjeldsen, Keld; Kuck, Karl-Heinz; Hernandez-Madrid, Antonio; Nikolaou, Nikolaos; Norekvål, Tone M.; Spaulding, Christian; Van Veldhuisen, Dirk J. (2015). "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". European Heart Journal. 36 (41): 2793–2867. doi:10.1093/eurheartj/ehv316. ISSN 0195-668X.